The treatment of patients with metastatic rectal cancer remains controversial. We developed a reverse strategy, the liver-first approach, to optimize the chance of a curative resection. The aim of this study was to assess rectal outcomes after reverse treatment of patients with metastatic rectal cancer
Background and Objective. Colorectal cancer is a major health concern as a very common cancer and a ...
International audienceOBJECTIVES:Multicenter studies comparing the reverse strategy (RS) with the cl...
Background: Patients presenting with synchronous colorectal liver metastases are increasingly being ...
Background: The treatment of patients with metastatic rectal cancer remains controversial. We develo...
Objective: to evaluate feasibility and short-term results of the liver-first approach in our center....
PURPOSE: This study was designed to investigate the outcome of "the liver-first" approach in patient...
BACKGROUND: There are no reports available on the long-term outcome of patients with the "liver firs...
In the last few decades there have been significant changes in the approach to rectal cancer managem...
Background and Objectives: The optimal treatment sequence in stage IV rectal cancer (RC) with synchr...
The article comment the multidisciplinary reverse approach for the treatment of primary rectal cance...
Background: This study evaluated the outcome of patients treated for rectal cancer and synchronous h...
BACKGROUND: This study evaluated the outcome of patients treated for rectal cancer and synchronous h...
AIM: A total of 15-20% of patients with rectal cancer have liver metastases on presentation. The man...
Aim: A total of 15–20% of patients with rectal cancer have liver metastases on presentation. The man...
BACKGROUND: A total of 15-20% of patients with rectal cancer patients have liver metastases on pres...
Background and Objective. Colorectal cancer is a major health concern as a very common cancer and a ...
International audienceOBJECTIVES:Multicenter studies comparing the reverse strategy (RS) with the cl...
Background: Patients presenting with synchronous colorectal liver metastases are increasingly being ...
Background: The treatment of patients with metastatic rectal cancer remains controversial. We develo...
Objective: to evaluate feasibility and short-term results of the liver-first approach in our center....
PURPOSE: This study was designed to investigate the outcome of "the liver-first" approach in patient...
BACKGROUND: There are no reports available on the long-term outcome of patients with the "liver firs...
In the last few decades there have been significant changes in the approach to rectal cancer managem...
Background and Objectives: The optimal treatment sequence in stage IV rectal cancer (RC) with synchr...
The article comment the multidisciplinary reverse approach for the treatment of primary rectal cance...
Background: This study evaluated the outcome of patients treated for rectal cancer and synchronous h...
BACKGROUND: This study evaluated the outcome of patients treated for rectal cancer and synchronous h...
AIM: A total of 15-20% of patients with rectal cancer have liver metastases on presentation. The man...
Aim: A total of 15–20% of patients with rectal cancer have liver metastases on presentation. The man...
BACKGROUND: A total of 15-20% of patients with rectal cancer patients have liver metastases on pres...
Background and Objective. Colorectal cancer is a major health concern as a very common cancer and a ...
International audienceOBJECTIVES:Multicenter studies comparing the reverse strategy (RS) with the cl...
Background: Patients presenting with synchronous colorectal liver metastases are increasingly being ...